Non-invasive gene expression profile test shown to identify sentinel lymph node negative melanoma patients at high risk of metastasis

Castle Biosciences Inc. has announced study results showing its gene expression profile (GEP) test (DecisionDx-Melanoma) can identify primary cutaneous (skin) melanoma tumors that are likely to...